IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 238 filers reported holding IMMUNOGEN INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,659,459 | +732.7% | 167,578 | +890.1% | 0.00% | – |
| Q2 2023 | $319,394 | +83.2% | 16,926 | -62.7% | 0.00% | – |
| Q1 2023 | $174,367 | -11.6% | 45,408 | +14.2% | 0.00% | – |
| Q4 2022 | $197,160 | -80.4% | 39,750 | -81.1% | 0.00% | -100.0% |
| Q3 2022 | $1,007,000 | -3.1% | 210,737 | -8.7% | 0.00% | 0.0% |
| Q2 2022 | $1,039,000 | -9.8% | 230,874 | -4.6% | 0.00% | 0.0% |
| Q1 2022 | $1,152,000 | -38.9% | 241,940 | -4.7% | 0.00% | -50.0% |
| Q4 2021 | $1,884,000 | +28.2% | 253,872 | -2.1% | 0.00% | +100.0% |
| Q3 2021 | $1,470,000 | -15.1% | 259,267 | -1.4% | 0.00% | -50.0% |
| Q2 2021 | $1,732,000 | -20.4% | 262,838 | -2.2% | 0.00% | 0.0% |
| Q1 2021 | $2,177,000 | +24.5% | 268,789 | -0.8% | 0.00% | 0.0% |
| Q4 2020 | $1,748,000 | +67.1% | 271,008 | -6.7% | 0.00% | +100.0% |
| Q3 2020 | $1,046,000 | -27.4% | 290,457 | -7.3% | 0.00% | -50.0% |
| Q2 2020 | $1,441,000 | +42.1% | 313,307 | +5.4% | 0.00% | 0.0% |
| Q1 2020 | $1,014,000 | -62.8% | 297,226 | -44.3% | 0.00% | -33.3% |
| Q4 2019 | $2,727,000 | +93.1% | 534,089 | -8.5% | 0.00% | +50.0% |
| Q3 2019 | $1,412,000 | +9.5% | 583,435 | -1.8% | 0.00% | 0.0% |
| Q2 2019 | $1,289,000 | -23.2% | 594,026 | -4.1% | 0.00% | -33.3% |
| Q1 2019 | $1,678,000 | -41.3% | 619,323 | +4.0% | 0.00% | -40.0% |
| Q4 2018 | $2,859,000 | -53.5% | 595,549 | -8.2% | 0.01% | -44.4% |
| Q3 2018 | $6,144,000 | -2.7% | 648,833 | +0.0% | 0.01% | -18.2% |
| Q2 2018 | $6,312,000 | -4.0% | 648,758 | +3.8% | 0.01% | -8.3% |
| Q1 2018 | $6,578,000 | +65.7% | 625,299 | +1.0% | 0.01% | +71.4% |
| Q4 2017 | $3,970,000 | +13.4% | 619,357 | +35.3% | 0.01% | 0.0% |
| Q3 2017 | $3,502,000 | -10.1% | 457,754 | -16.5% | 0.01% | -12.5% |
| Q2 2017 | $3,896,000 | +60.3% | 547,917 | -12.8% | 0.01% | +33.3% |
| Q1 2017 | $2,431,000 | +85.6% | 628,236 | -2.2% | 0.01% | +100.0% |
| Q4 2016 | $1,310,000 | -25.6% | 642,160 | -2.3% | 0.00% | -40.0% |
| Q3 2016 | $1,761,000 | -11.6% | 657,202 | +1.7% | 0.01% | -16.7% |
| Q2 2016 | $1,991,000 | -62.8% | 646,440 | +3.0% | 0.01% | -66.7% |
| Q1 2016 | $5,346,000 | -36.0% | 627,424 | +2.0% | 0.02% | -40.0% |
| Q4 2015 | $8,350,000 | +46.6% | 615,361 | +3.7% | 0.03% | +30.4% |
| Q3 2015 | $5,696,000 | -29.7% | 593,371 | +5.3% | 0.02% | -25.8% |
| Q2 2015 | $8,103,000 | +76.5% | 563,515 | +9.8% | 0.03% | +55.0% |
| Q1 2015 | $4,592,000 | +81.9% | 513,071 | +23.9% | 0.02% | +66.7% |
| Q4 2014 | $2,525,000 | -17.6% | 413,978 | +43.1% | 0.01% | -33.3% |
| Q3 2014 | $3,063,000 | -1.0% | 289,233 | +10.8% | 0.02% | -5.3% |
| Q2 2014 | $3,095,000 | -6.7% | 261,155 | +17.5% | 0.02% | -17.4% |
| Q1 2014 | $3,318,000 | +17.2% | 222,239 | +15.2% | 0.02% | +9.5% |
| Q4 2013 | $2,830,000 | +0.7% | 192,925 | +16.9% | 0.02% | -12.5% |
| Q3 2013 | $2,809,000 | +15.6% | 165,013 | +12.6% | 0.02% | +4.3% |
| Q2 2013 | $2,430,000 | – | 146,496 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 10,906,962 | $69,914,000 | 3.04% |
| Fernwood Investment Management, LLC | 224,500 | $1,439,000 | 0.77% |
| Telemetry Investments, L.L.C. | 272,000 | $1,744,000 | 0.66% |
| Schonfeld Strategic Advisors LLC | 865,356 | $5,547,000 | 0.45% |
| Virtus ETF Advisers LLC | 53,977 | $346,000 | 0.43% |
| Endurant Capital Management LP | 210,800 | $1,351,000 | 0.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $3,205,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $726,000 | 0.37% |
| Orbimed Advisors | 2,834,126 | $18,167,000 | 0.23% |
| PINNACLE ASSOCIATES LTD | 1,322,231 | $8,476,000 | 0.16% |